PetMed Express Stock Is Believed To Be Fairly Valued
- By GF Value
The stock of PetMed Express (NAS:PETS, 30-year Financials) is estimated to be fairly valued, according to GuruFocus Value calculation. GuruFocus Value is GuruFocus' estimate of the fair value at which the stock should be traded. It is calculated based on the historical multiples that the stock has traded at, the past business growth and analyst estimates of future business performance. If the price of a stock is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher. At its current price of $33.11 per share and the market cap of $671.2 million, PetMed Express stock is believed to be fairly valued. GF Value for PetMed Express is shown in the chart below.
Because PetMed Express is fairly valued, the long-term return of its stock is likely to be close to the rate of its business growth, which averaged 5% over the past three years and is estimated to grow 3.65% annually over the next three to five years.
Link: These companies may deliever higher future returns at reduced risk.
Companies with poor financial strength offer investors a high risk of permanent capital loss. To avoid permanent capital loss, an investor must do their research and review a company's financial strength before deciding to purchase shares. Both the cash-to-debt ratio and interest coverage of a company are a great way to to understand its financial strength. PetMed Express has a cash-to-debt ratio of 10000.00, which which ranks better than 100% of the companies in the industry of Healthcare Providers & Services. The overall financial strength of PetMed Express is 9 out of 10, which indicates that the financial strength of PetMed Express is strong. This is the debt and cash of PetMed Express over the past years:
It is less risky to invest in profitable companies, especially those with consistent profitability over long term. A company with high profit margins is usually a safer investment than those with low profit margins. PetMed Express has been profitable 10 over the past 10 years. Over the past twelve months, the company had a revenue of $311.8 million and earnings of $1.54 a share. Its operating margin is 12.09%, which ranks better than 77% of the companies in the industry of Healthcare Providers & Services. Overall, the profitability of PetMed Express is ranked 8 out of 10, which indicates strong profitability. This is the revenue and net income of PetMed Express over the past years:
Growth is probably the most important factor in the valuation of a company. GuruFocus research has found that growth is closely correlated with the long term performance of a company's stock. The faster a company is growing, the more likely it is to be creating value for shareholders, especially if the growth is profitable. The 3-year average annual revenue growth rate of PetMed Express is 5%, which ranks in the middle range of the companies in the industry of Healthcare Providers & Services. The 3-year average EBITDA growth rate is -4.6%, which ranks worse than 72% of the companies in the industry of Healthcare Providers & Services.
Another way to evaluate a company's profitability is to compare its return on invested capital (ROIC) to its weighted cost of capital (WACC). Return on invested capital (ROIC) measures how well a company generates cash flow relative to the capital it has invested in its business. The weighted average cost of capital (WACC) is the rate that a company is expected to pay on average to all its security holders to finance its assets. If the ROIC is higher than the WACC, it indicates that the company is creating value for shareholders. Over the past 12 months, PetMed Express's ROIC was 83.64, while its WACC came in at 5.33. The historical ROIC vs WACC comparison of PetMed Express is shown below:
Overall, The stock of PetMed Express (NAS:PETS, 30-year Financials) gives every indication of being fairly valued. The company's financial condition is strong and its profitability is strong. Its growth ranks worse than 72% of the companies in the industry of Healthcare Providers & Services. To learn more about PetMed Express stock, you can check out its 30-year Financials here.
To find out the high quality companies that may deliever above average returns, please check out GuruFocus High Quality Low Capex Screener.
This article first appeared on GuruFocus.
